Anticoagulation  5 Total

What Are the Key Takeaways from the State-of-the-Art Session for Guidelines Associated with Diagnosis and Treatment of TTP?

What Are the Key Takeaways from the State-of-the-Art Session for Guidelines Associated with Diagnosis and Treatment of TTP?

In this session of ISTH TV, Drs. Paul Coppo and Long Xheng discuss the key takeaways from the 2020 Virtual Meeting. This includes discussion of the first guidelines on TTP and the implications they have on clinicians. They also discuss results of the Hercules 3 Trial.
Key Findings/Learnings from the 2020 Meeting Related to Anticoagulation

Key Findings/Learnings from the 2020 Meeting Related to Anticoagulation

Drs. Jeffrey Weitz and Saskia Middledorp discuss the information discussed at the 2020 ISTH Virtual Congress. Topics include new information about the use of aspirin, unusual site thrombosis, and major trials released during the meeting.

COVID-19, Anticoagulation, and the 2020 Virtual ISTH Meeting

COVID-19, Anticoagulation, and the 2020 Virtual ISTH Meeting

Drs. Jeffrey Weitz and Saskia Middledorp discuss how COVID-19 has impacted thromboembolism and ultimately anticoagulation management. They discuss the COVID-19 coagulopathy, its risk, and how to best prevent thrombosis.
What Advancements Have Been Made in Anticoagulation Management in Special Populations?

What Advancements Have Been Made in Anticoagulation Management in Special Populations?

Dr. Beverley Hunt, Dr. Alexander Cohen, and Prof. Saskia Middeldorp discuss advancements that have been made in special populations related to anticoagulation management.
Is Anticoagulation Reversal Needed/Warranted with Latest Data?

Is Anticoagulation Reversal Needed/Warranted with Latest Data?

Dr. Beverley Hunt, Dr. Jean Connors, and Dr. Jeffrey Weitz discussed key considerations associated with anticoagulation reversal and whether it is warranted with the latest data available.

Hemophilia  3 Total

Discussing the Impact COVID-19 Has Had on Hemophilia Management and the Major Findings from the 2020 Virtual Meeting

Discussing the Impact COVID-19 Has Had on Hemophilia Management and the Major Findings from the 2020 Virtual Meeting

In this discussion, the panel discusses the impact COVID-19 has had on hemophilia management. They also review late breaking information presented at the 2020 virtual congress and important initiatives currently underway with the ISTH.
Advancing Care for Hemophilia – Insights from the 2020 Meeting

Advancing Care for Hemophilia – Insights from the 2020 Meeting

At the 2020 meeting several scientific works provided information which directly changes practice. The panel discussed practice changes that can be implemented in hemophilia A and B.
What are the 3-4 Major Findings from the 2020 Virtual Meeting?

What are the 3-4 Major Findings from the 2020 Virtual Meeting?

The ISTH Virtual meeting provided a venue for key findings in hemophilia. In this discussion, the panel discusses the several major findings.